Lisa Anson is currently President of AstraZeneca UK and President of the ABPI where she has chaired a number of UK industry committees. Prior to her current role she held a number of senior roles in AstraZeneca plc, including Vice President of Emerging Brands, where she was the commercial member on Global Governance Groups for the organisation's research and development programmes. She has extensive global commercial leadership experience both as Vice President, Oncology and as Vice President, Mental Health where she led the global cross functional product team, launching products in multiple markets worldwide. Within AstraZeneca, Lisa has held a number of sales and marketing leadership roles in both the UK and US.
Prior to joining AstraZeneca, Lisa worked in US Healthcare at a California-based disease management company. She started her career in Strategy Consulting with KPMG in London. She holds a MBA with distinction from INSEAD in France and a First Class degree in Natural Sciences from Cambridge University in the UK. Lisa currently lives in Cheshire with her husband Andy and her three children.